Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1605)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3722)
  2. Department of Medicine (3691)
  3. Hematologic Malignancies, Division of (3687)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (389)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (105)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (325)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3722)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Primary myelofibrosis: Update on definition, pathogenesis, and treatment
    Journal Article

    Abdel-Wahab, O. I.; Levine, R. L.
    Annual Review of Medicine (2009)

    Fulltext@MSK | Save
  • Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
    Journal Article

    Abdel-Wahab, O.; Mullally, A.; Hedvat, C.; Garcia-Manero, G.; Patel, J.; Wadleigh, M.; Malinge, S.; Yao, J.; Kilpivaara, O.; Bhat, R.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • A new pathway for processing mitochondrial-DNA encoded proteins is essential to mitochondrial energy production in human cancer cells
    Meeting Abstract

    Alvarez, S. N. E.; Gardner, J.; Sheth, A.; Yang, G.; Ouerfelli, O.; Manfredi, G.; Heaney, M. L.; Scheinberg, D. A.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Pilot trial of a Wilms tumor-1 (WT1) peptide vaccine in patients with thoracic and myeloid neoplasms
    Meeting Abstract

    Brown, A. B.; Krug, L. M.; Maslak, P.; James, L. P.; Dao, T.; Tyson, L.; Chanel, S. M.; Bekele, S.; Scheinberg, D. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • A phase I trial for the treatment of purine analog-refractory chronic lymphocytic leukemia using autologous T cells genetically targeted to the B cell specific antigen CD19
    Meeting Abstract

    Brentjens, R. J.; Hollyman, D.; Weiss, M.; Stefanski, J.; Przybylowski, M.; Bartido, S.; Borquez-Ojeda, O.; Taylor, C.; Heaney, M.; Riviere, I.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Novel monoclonal antibodies detects external portion of the MUC16 in ovarian carcinoma
    Meeting Abstract

    Thapi, D.; Park, K. J.; Soslow, R. A.; Linkov, I.; Spriggs, D. R.
    Cancer Research (2008)

    Fulltext@MSK | Save
  • Muc16 carboxyl portion expression alternates PI3K/Akt and EGFR/HER2/ERK signal pathways in human ovarian cells
    Meeting Abstract

    Ma, X.; Thapi, D.; Yan, X.; She, Q.; Rosales, N.; Spriggs, D. R.
    Cancer Research (2008)

    Fulltext@MSK | Save
  • CD32B expression reflects phenotypic and functional heterogeneity in multiple myeloma (MM)
    Meeting Abstract

    Zhou, P.; Boruchov, A. M.; Hoffman, J. E.; Mo, Q. X.; Olshen, A.; Glasner, E.; Bonvini, E.; Koenig, S.; Drieghe, E.; Fleisher, M.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Integrative analysis of genomic aberration and gene expression suggests that MPD with loss of heterozygosity or gain of chromosome 9 represents a distinct entity
    Meeting Abstract

    Zhang, W. J.; Ebert, B. L.; Berkofsky-Fessler, W.; Buzzai, M.; Sun, Y. Z.; Xi, C. X.; Levine, R. L.; Gilliland, G.; Licht, J. D.
    Blood (2008)

    Fulltext@MSK | Save
  • Co-treatment with JAK2 inhibitor TC101209 and panobinostat or hsp90 inhibitor AUY922 attenuates mutant JAK2-V617F levels and activity in human myeloproliferative disorder cells
    Meeting Abstract

    Wang, Y. C.; Fiskus, W.; Natarajan, K.; Jillella, A.; Quadt, C.; Ataja, P.; Levine, R.; Bhalla, K. N.
    Blood (2008)

    Fulltext@MSK | Save